Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Cited In for PubMed (Select 12802023)

1.

Maternal Serum Screening Markers and Adverse Outcome: A New Perspective.

Krantz D, Hallahan T, Janik D, Carmichael J.

J Clin Med. 2014 Jul 3;3(3):693-712. doi: 10.3390/jcm3030693. Review.

2.

Recent advances in the prevention and management of preterm birth.

Tan MY, To M.

F1000Prime Rep. 2015 Apr 2;7:40. doi: 10.12703/P7-40. eCollection 2015. Review.

3.

Disparities and relative risk ratio of preterm birth in six Central and Eastern European centers.

Arora CP, Kacerovsky M, Zinner B, Ertl T, Ceausu I, Rusnak I, Shurpyak S, Sandhu M, Hobel CJ, Dumesic DA, Vari SG.

Croat Med J. 2015 Apr;56(2):119-27.

4.

STOPPIT Baby Follow-up Study: the effect of prophylactic progesterone in twin pregnancy on childhood outcome.

McNamara HC, Wood R, Chalmers J, Marlow N, Norrie J, MacLennan G, McPherson G, Boachie C, Norman JE.

PLoS One. 2015 Apr 16;10(4):e0122341. doi: 10.1371/journal.pone.0122341. eCollection 2015.

5.

Hypercholesterolaemia in pregnancy as a predictor of adverse pregnancy outcome.

Maymunah AO, Kehinde O, Abidoye G, Oluwatosin A.

Afr Health Sci. 2014 Dec;14(4):967-73. doi: 10.4314/ahs.v14i4.28.

6.

The Effect of Progestins on Tumor Necrosis Factor α-Induced Matrix Metalloproteinase-9 Activity and Gene Expression in Human Primary Amnion and Chorion Cells In Vitro.

Allen TK, Feng L, Nazzal M, Grotegut CA, Buhimschi IA, Murtha AP.

Anesth Analg. 2015 May;120(5):1085-94. doi: 10.1213/ANE.0000000000000708.

PMID:
25806402
7.

Neuroprotection in preterm infants.

Berger R, Söder S.

Biomed Res Int. 2015;2015:257139. doi: 10.1155/2015/257139. Epub 2015 Jan 11.

8.

On the significance of new biochemical markers for the diagnosis of premature labour.

Rzepka R, Dołęgowska B, Rajewska A, Kwiatkowski S.

Mediators Inflamm. 2014;2014:251451. doi: 10.1155/2014/251451. Epub 2014 Dec 8.

9.

Progesterone-induced activation of membrane-bound progesterone receptors in murine macrophage cells.

Lu J, Reese J, Zhou Y, Hirsch E.

J Endocrinol. 2015 Feb;224(2):183-94. doi: 10.1530/JOE-14-0470. Epub 2014 Dec 3.

10.

Maternal characteristics influencing the development of gestational diabetes in obese women receiving 17-alpha-hydroxyprogesterone caproate.

Egerman R, Ramsey R, Istwan N, Rhea D, Stanziano G.

J Obes. 2014;2014:563243. doi: 10.1155/2014/563243. Epub 2014 Oct 27.

11.
12.

Prematurity: present and future.

Tsimis ME, Abu Al-Hamayel N, Germaine H, Burd I.

Minerva Ginecol. 2015 Feb;67(1):35-46. Epub 2014 Oct 10.

13.

Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.

Feghali M, Venkataramanan R, Caritis S.

Semin Perinatol. 2014 Dec;38(8):516-22. doi: 10.1053/j.semperi.2014.08.013. Epub 2014 Sep 23. Review.

PMID:
25256193
14.

Preterm labor: one syndrome, many causes.

Romero R, Dey SK, Fisher SJ.

Science. 2014 Aug 15;345(6198):760-5. doi: 10.1126/science.1251816. Epub 2014 Aug 14. Review.

15.

HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction.

Papp E, Mohammadi H, Loutfy MR, Yudin MH, Murphy KE, Walmsley SL, Shah R, MacGillivray J, Silverman M, Serghides L.

J Infect Dis. 2015 Jan 1;211(1):10-8. doi: 10.1093/infdis/jiu393. Epub 2014 Jul 16.

16.

Mechanical signaling in reproductive tissues: mechanisms and importance.

Jorge S, Chang S, Barzilai JJ, Leppert P, Segars JH.

Reprod Sci. 2014 Sep;21(9):1093-107. doi: 10.1177/1933719114542023. Epub 2014 Jul 6. Review.

PMID:
25001021
17.

The uterine myocyte as a target for prevention of preterm birth.

Mitchell BF, Aguilar HN, Mosher A, Wood S, Slater DM.

Facts Views Vis Obgyn. 2013;5(1):72-81. Review.

18.
19.

Progesterone action in the myometrium and decidua in preterm birth.

Blanks AM, Brosens JJ.

Facts Views Vis Obgyn. 2012;4(3):33-43. Review.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk